| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Lin Elizabeth Yeu is a Chief Medical Officer at Tarsus Pharmaceuticals, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 2,078 | $79.50 | $165,201.00 | -8.7% | -12.0% | - | |
| Jun 16, 2025 | TARS Tarsus Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 1,006 | $41.08 | $41,326.48 | -11.6% | +20.1% | - | |
| Sep 21, 2023 | STAA Staar Surgical Co | Director | Buy | 2,500 | $40.00 | $100,000.00 | +704.2% | -21.4% | -22.8% | |
| Aug 15, 2023 | TARS Tarsus Pharmaceuticals, Inc. | Director | Buy | 9,506 | $16.80 | $159,700.80 | +149.5% | +1.0% | +56.8% | |
| Sep 14, 2022 | TARS Tarsus Pharmaceuticals, Inc. | Director | Buy | 18,400 | $16.12 | $296,605.60 | New | -6.8% | -9.3% |